ATE174597T1 - Tan-1251-verbindung, ihre derivate, herstellung und verwendung - Google Patents

Tan-1251-verbindung, ihre derivate, herstellung und verwendung

Info

Publication number
ATE174597T1
ATE174597T1 AT91904808T AT91904808T ATE174597T1 AT E174597 T1 ATE174597 T1 AT E174597T1 AT 91904808 T AT91904808 T AT 91904808T AT 91904808 T AT91904808 T AT 91904808T AT E174597 T1 ATE174597 T1 AT E174597T1
Authority
AT
Austria
Prior art keywords
pct
hydrogen
compound
acylated
sec
Prior art date
Application number
AT91904808T
Other languages
English (en)
Inventor
Hideo Shirafuji
Shigetoshi Tsubotani
Takenori Ishimaru
Setsuo Harada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE174597T1 publication Critical patent/ATE174597T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/933—Penicillium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT91904808T 1990-03-06 1991-03-05 Tan-1251-verbindung, ihre derivate, herstellung und verwendung ATE174597T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5574990 1990-03-06
JP3610791 1991-03-01
JP3726891 1991-03-04

Publications (1)

Publication Number Publication Date
ATE174597T1 true ATE174597T1 (de) 1999-01-15

Family

ID=27288978

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904808T ATE174597T1 (de) 1990-03-06 1991-03-05 Tan-1251-verbindung, ihre derivate, herstellung und verwendung

Country Status (9)

Country Link
US (1) US5310741A (de)
EP (1) EP0532752B1 (de)
JP (1) JP3153959B2 (de)
AT (1) ATE174597T1 (de)
CA (1) CA2077672A1 (de)
DE (1) DE69130643T2 (de)
DK (1) DK0532752T3 (de)
ES (1) ES2125235T3 (de)
WO (1) WO1991013887A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1564284A1 (de) 2004-02-11 2005-08-17 Urea Casale S.A. Kulturmedium zur Produktion filamentöser Pilze

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2885499B2 (ja) * 1990-09-26 1999-04-26 日本電信電話株式会社 情報記録部材

Also Published As

Publication number Publication date
WO1991013887A1 (en) 1991-09-19
EP0532752A1 (de) 1993-03-24
EP0532752B1 (de) 1998-12-16
DE69130643D1 (de) 1999-01-28
US5310741A (en) 1994-05-10
CA2077672A1 (en) 1991-09-07
DK0532752T3 (da) 1999-06-23
JPH06501916A (ja) 1994-03-03
DE69130643T2 (de) 1999-05-06
ES2125235T3 (es) 1999-03-01
JP3153959B2 (ja) 2001-04-09

Similar Documents

Publication Publication Date Title
DE69331190D1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
DE69327541D1 (en) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
DE69329386D1 (de) Substituierte benzylaminoquinuclidine als substanz p antagonisten
DE69429984D1 (de) In position 3 durch eine stickstoffgruppe substituierte 1,3-dihydroindol-2-on derivate als vasopressin und/oder ocytocin agonisten und/oder antagonisten
ATE235476T1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
ES468119A1 (es) Un procedimiento para la preparacion de triazinas
HUT60464A (en) Process for producing n-phenylbenzamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DK0738269T5 (da) Piperidinderivater med PAF-antagonistaktivitet
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ATE156119T1 (de) 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel
SE9102909D0 (sv) New use
TW354762B (en) Agent for prophylaxis or treatment of cataract
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
DE69130643D1 (de) Tan-1251-verbindung, ihre derivate, herstellung und verwendung
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
FR2778404B1 (fr) Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
ATE148463T1 (de) N-acyl-substituierte azazyklische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
IL105122A0 (en) Benzimidazole derivative for use as an anti-irritant
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
MY115907A (en) Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
ATE129702T1 (de) Sulfonamidderivat und dieses enthaltende arzneimittel.
TR199800407T1 (xx) 4-(Sikloalkil) piperidin ve t�revleri, haz�rlan��lar�, tedavi ama�l� kullan�mlar�.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee